Helen Shum

Helen Shum practices at Port Jefferson Station Medical Oncology in Ridge, New York.

Helen Shum's NPI, 1821227273, was assigned on July 7, 2009. Helen Shum holds New York license 279134.

Helen Shum's primary practice is Port Jefferson Station Medical Oncology, at 1 Research Rd, Ridge, NY 11961. The practice phone is (631) 751-3000.

Helen Shum's primary practice is Port Jefferson Station Medical Oncology in Ridge, New York. Helen Shum is also affiliated with Tisch Hospital. The medical group on file is New York Cancer & Blood Specialists. Dmand AI also links Helen Shum to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Helen Shum practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Helen Shum's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Helen Shum's licenses on file in 2 states: New York and Rhode Island.

CMS data shows 38,929 Medicare services from Helen Shum across 63 procedure codes in 2024, for 776 Medicare patients. Medicare paid $404,444 for them.

CMS counts 776 Medicare patients who saw Helen Shum in 2024. The largest group is 65 to 74, with 280 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Helen Shum's median patient age at 56, with 68% women.

In 2024, Helen Shum wrote 1,417 Medicare Part D claims for 234 patients. 50% of them were for generic drugs. CMS names the drug for 1,055 of them, across 38 drugs with 11 or more claims each, at $2,998,415 in total drug cost. In 2023, CMS named 1,027 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Helen Shum for performance year 2024, reported as part of a group. Helen Shum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Helen Shum as offering telehealth.

Dmand AI links 4 papers to Helen Shum, published from 2011 to 2012. Helen Shum has published most often in World J Gastrointest Oncol. Helen Shum's most frequent co-authors are Lakshmi N. Rajdev, MD, James N. Butera, MD and Jorge J. Castillo, MD.

CMS Open Payments shows 243 general payments to Helen Shum from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Novartis Pharmaceuticals Corporation paid the most, $675.